Medication info
Nexiten Tablets 40mg (Esomeprazole Magnesium Trihydrate)

Nexiten Tablets 40mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Trihydrate›44.5mg / 1 tablet
Manufacturer / importer
LitePharmTech Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
28 tablets/box [14 tablets/Alu-Alu×2]
Approval status
Active

MFDS item code 201906673 · Approved 2019.09.24

Summary

Main use
Treatment of gastroesophageal reflux disease, gastrointestinal disorders (such as ulcers and Helicobacter pylori infection), and Zollinger-Ellison syndrome
Who uses it
Adults · Children
Adult dosage
This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. 20 mg once daily 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric or duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs, as-needed administration is not recommended for control of persistent symptoms. Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Clinical trials lasting longer than 4 weeks have not been conducted. 20 mg once daily. The treatment duration is 4∼8 weeks. 20 mg once daily. The recommended initial dose is 40 mg twice daily. Subsequent doses should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided into 2 doses. Administer 40 mg once daily for 4 weeks after induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection. No dose adjustment is necessary. Since there is limited experience administering this medicine to patients with severe renal impairment, it should be administered with caution. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. No dose adjustment is necessary.
Children's dosage
Adolescents aged 12 years and older: Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Adolescents aged 12 years and older: For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Adolescents aged 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Adolescents aged 12 years and older: Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Children under 12 years: There is no experience with administering this medicine to children under 12 years of age.

Ingredients

Manufacturer
LitePharmTech Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, gastrointestinal disorders (such as ulcers and Helicobacter pylori infection), and Zollinger-Ellison syndrome

  • Gastroesophageal reflux disease
  • erosive reflux esophagitis
  • esophagitis
  • Helicobacter pylori-positive duodenal ulcer
  • peptic ulcer
  • upper gastrointestinal pain
  • upper gastrointestinal discomfort
  • upper gastrointestinal burning sensation
  • gastric ulcer
  • duodenal ulcer
  • Zollinger-Ellison syndrome
  • rebleeding.
View approved original text

This medication is used for the treatment of gastroesophageal reflux disease, particularly erosive reflux esophagitis, and for maintenance therapy to prevent relapse in patients with esophagitis. Additionally, it helps treat and prevent recurrence of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection. It is also effective for the treatment of upper gastrointestinal symptoms and gastric ulcers caused by the use of non-steroidal anti-inflammatory drugs, as well as for the prevention of gastric ulcers and duodenal ulcers. It is used in the treatment of Zollinger-Ellison syndrome and for maintenance therapy to prevent bleeding due to gastric ulcers or duodenal ulcers. In summary, this medication is widely used for the treatment and prevention of various gastrointestinal diseases.

Dosage and Administration

Adult dosage

This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. 20 mg once daily 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric or duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs, as-needed administration is not recommended for control of persistent symptoms. Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Clinical trials lasting longer than 4 weeks have not been conducted. 20 mg once daily. The treatment duration is 4∼8 weeks. 20 mg once daily. The recommended initial dose is 40 mg twice daily. Subsequent doses should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided into 2 doses. Administer 40 mg once daily for 4 weeks after induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection. No dose adjustment is necessary. Since there is limited experience administering this medicine to patients with severe renal impairment, it should be administered with caution. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. No dose adjustment is necessary.

Children's dosage

Adolescents aged 12 years and older: Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Adolescents aged 12 years and older: For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Adolescents aged 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is required. Adolescents aged 12 years and older: Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. Children under 12 years: There is no experience with administering this medicine to children under 12 years of age.

Precautions

This medication should not be used in certain patients. Patients who are allergic to this medication or any of its components, or who have experienced hypersensitivity reactions to benzimidazole derivatives should not take this medication. Additionally, patients who are allergic to penicillin-based or macrolide antibiotics should not use this medication when combined with amoxicillin or clarithromycin for the eradication of Helicobacter pylori. Patients taking certain heart-related medications or antivirals, as well as nursing women, should also avoid taking this medication. Adverse effects may occur with this medication, so caution is needed. Common gastrointestinal symptoms such as headache, abdominal pain, diarrhea, nausea, and vomiting may occur. Rarely, serious symptoms such as blood disorders, hypersensitivity, and hypomagnesemia have been reported. If symptoms such as myalgia, weakness, or arrhythmia occur, consult a doctor immediately. Regular examinations are necessary with long-term use of this medication. When taking for more than a year, magnesium levels in the blood should be monitored regularly, and since there may be an increased risk of fractures, bone density tests are also recommended. Additionally, if symptoms suggestive of malignancy occur, malignancy must be ruled out before taking this medication. This medication may interact with other drugs, so patients should inform their doctor or pharmacist of any medications they are currently taking. Care should be taken, especially when used with anticoagulants like warfarin, antivirals, anticonvulsants, antidepressants, etc., and dosage adjustments or monitoring may be required. Data on the safety of this medication in pregnancy is limited, so women who are pregnant or planning to become pregnant should consult a healthcare professional before taking this medication. It is recommended that nursing women do not take this medication. In case of overdose, there is no specific antidote, so treatment according to symptoms and general maintenance therapy is required. It should be kept out of reach of children and should not be stored in other containers.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reactions, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, taste disturbances, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, eosinophilia, drug reactions accompanied by systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, focal segmental glomerulosclerosis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reactions, back pain, chest pain, substernal pain, facial swelling, facial flushing, fatigue, fever, flu-like disorder, generalized edema, leg swelling, lassitude, pain, rigidity, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, aggravated constipation, indigestion, dysphagia, gastrointestinal dysplasia, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, black stools, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, ear pain, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver function abnormalities, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, anorexia, apathy, increased appetite, confusion, exacerbation of depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, visual field defects, conjunctivitis, visual disturbances, otitis media, dysosmia, ageusia, dysgeusia, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infections, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, duodenitis, esophagitis, esophageal stricture, esophageal ulcers, esophageal varices, gastric ulcers, gastritis, benign polyps, mucosal discoloration, fractures, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture. It is important to maintain the storage temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

28 tablets/box [14 tablets/Alu-Alu×2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.